Nitric oxide plays a critical role in the recovery of lewis rats from experimental autoimmune encephalomyelitis and the maintenance of resistance to reinduction

Journal of Immunology

Volumn 163, Issue 12, 1999, Pages 6841-6847

  O'Brien, Nikki C ^a,b   Charlton, Brett ^b   Cowden, William B ^b   Willenborg, David O ^a  

^a CANBERRA HOSPITAL   (Australia)

^b Biology and Environment   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; IMMUNIZATION; MULTIPLE SCLEROSIS; NONHUMAN; PARESIS; PRIORITY JOURNAL; RAT; RELAPSE;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FREE RADICALS; FREUND'S ADJUVANT; GUINEA PIGS; IMMUNITY, NATURAL; INJECTIONS, INTRADERMAL; MYELIN BASIC PROTEINS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRITES; RATS; RATS, INBRED LEW; RECURRENCE; VACCINATION;

EID: 0032715755     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Raine, C. S., L. B. Barnett, A. Brown, and D. E. McFarlin. 1980. Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice. Lab. Invest. 43:150.
2. Ludowyk, P. A., W. Hughes, A. Hugh, D. O. Willenborg, K. A. Rockett, and C. R. Parish. 1993. Astrocytic hypertrophy: an important pathological feature of chronic experimental autoimmune encephalomyelitis in aged rats. J. Neuroimmunol. 48:121.
3. Ando, D. G., J. Clayton, D. Kono, J. L. Urban, and E. E. Sercarz. 1989. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine type. Cell. Immunol. 124:132.
4. Zamvil, S., and L. Steinman. 1990. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8:579.
5. Ruuls, S. R., and J. D. Sedgewick. 1998. Cytokine directed therapies in multiple sclerosis and experimental autoimmune encephalomyelitis. Immunol. Cell Biol. 76:65.
6. Becher, B., V. Dodelet, V. Fedorowicz, and J. P. Antel. 1996. Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. J. Clin. Invest. 98:1539.
7. Miossec, P., D. Cavender, and M. Ziff. 1986. Production of interleukin 1 by human endothelial cells. J. Immunol. 136:2486.
8. Sironi, M., F. Breviario, P. Proserpio, A. Biondi, A. Vecchi, J. Van Dame, E. Dejana, and A. Mantovani. 1989. IL-1 stimulates IL-6 production in endothelial cells. J. Immunol. 142:549.
9. Chung, I. Y., and E. N. Benveniste. 1990. Tumor necrosis factor production by astrocytes: Induction by lipopolysaccharide, interferon γ and interleukin-1. J. Immunol. 144:2999.
10. MacMicking, J. D., D. O. Willenborg, M. J. Weidemannn, K. A. Rockett, and W. B. Cowden. 1992. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells. J. Exp. Med. 176:303.
11. Lin, R. F., T. S. Lin, R. G. Tilton, and A. H. Cross. 1993. Nitric oxide localised to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study. J. Exp. Med. 178:643.
12. Kaprowski, H. S., Y. M. Zheng, E. Heber-Katz, N. Fraser, L. Rorke, Z. F. Fu, C. Hanlon, and B. Dietzschold. 1993. In vivo expression of inducible nitric oxide synthase in experimentally induced neurological diseases. Proc. Natl. Acad. Sci. USA 90:3024.
13. Okuda, Y., S., Sakoda, H. Fujimura, and T. Yanagihara. 1997. Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate cells from the central nervous system of mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 73:107.
14. Cross, A. H., T. P. Misko, R. F. Lin, R, W. F. Hickey, J. L. Trotter, and R. G. Tilton. 1994. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93:2684.
15. Cowden, W. B., F. A. Cullen, M. A. Staykova, and D. O. Willenborg. 1998. Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide renders PVG rats highly susceptible to EAE. J. Neuroimmunol. 88:1.
16. Ruuls, S. R., S. Van Der Linden, K. Sontrop, I. Huitinga, and C. D. Dijkstra. 1996. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin. Exp. Immunol. 103:467.
17. Willenborg, D. O. 1979. Experimental allergic encephalomyelitis in the Lewis rat: studies on the mechanism of recovery from disease and acquired resistance to reinduction. J. Immunol. 123:1145.
18. Hinrichs, D. J., C. M. Roberts, and F. J. Waxman. 1981. Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction. J. Immunol. 126:1857.
19. Willenborg, D. O. 1981. Mechanism of recovery and resistance in Lewis rat experimental allergic encephalomyelitis. Aust. J. Exp. Biol. Med. Sci. 59:125.
20. Eylar, E. H., S. Brostoff, G. Hashim, J. Caccam, and P. Burnett. 1971. Basic Al protein of the myelin membrane: the complete amino acid sequence. J. Biol. Chem. 246:5770.
21. G-mono-, di-, and trimethylated arginines. Acta Biochim. Biophys. Acad. Sci. Hung. 12:191.
22. Rockett, K. A., M. A. Awburn, B. B. Aggarwal, W. B. Cowden, and I. A. Clark, 1992. In vivo induction of nitrite and nitrate by tumor necrosis factor, lymphotoxin, and interleukin-1: possible roles in malaria. Infect. Immun. 60:3725.
23. Englert, D., and K. Hempel. 1981. Suppression of experimental allergic encephalomyelilis by transfer of lymph node cells from Lewis rats pretreated with complete Freund's adjuvant. Int. Arch. Allergy Appl. Immunol. 66:326.
24. Hempel, K., A. Freitag, B. Freitag, B. Endres, B. Mai, and G. Liebaldt. 1985. Unresponsiveness to experimental allergic encephalomyelitis in Lewis rats pretreated with complete Freund's adjuvant. Int. Arch. Allergy Appl. Immunol. 76: 193.
25. Welch, A. M., J. H. Holda, and R. H. Swanhorg. 1980. Regulation of experimental allergic encephalomyelitis. I. Differences between lymph node and spleen suppressor cells. J. Immunol. 125:186.
26. Kardys, E., and G. A. Hashim. 1981. Experimental allergic encephalomyelitis in the Lewis rats: immunoregulation of disease by a single amino acid substitution in the disease-inducing determinant. J. Immunol. 127:862.
27. Waxman, F. J., R. K. Bergman and J. J. Munoz. 1982. Abrogation of resistance to reinduction of experimental allergic encephalomyelitis by pertussigen. Cell. Immunol. 72:375.
28. Levine, S., R. Sowinski, and B. Steinetz. 1980. Effects of experimental allergic encephalomyelitis on thymus and adrenal: relation to remission and relapse. Proc. Soc. Exp. Biol. Med. 165:218.
29. MacPhee, I. A. M., and D. W. Mason. 1990. Studies on the refractoriness to reinduction of experimental allergic encephalomyelitis in Lewis rats that have recovered from one episode of the disease. J. Neuroimmunol. 27:9.
30. Mason, D. W., I. MacPhee, and F. Antoni. 1990. The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis. Immunology 70:1.
31. Willenborg, D. O. 1982. Total body irradiation allows re-induction of allergic encephalomyelitis in convalescent Lewis rats. Int. Arch. Allergy Appl. Immunol. 68:247.
32. MacPhee, I. A. M., M. J. Day, and D. W. Mason. 1990. The role of serum factors in the suppression of experimental autoimmune encephalomyelitis: evidence for immunoregulation by antibody to the encephalitogenic peptide. Immunology 70: 527.
33. Swierkosz, J. E., and R. H. Swanborg. 1975. Suppressor cell control of unresponsiveness to experimental allergic encephalomyelitis. J. Immunol. 115:631.
34. Welch, A. M., J. H. Holda, and R. H. Swanborg. 1980. Regulation of experimental allergic encephalomyelitis. II. Appearance of suppressor cells during the remission phase of the disease. J. Immunol. 125:186.
35. + suppressor cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by IL-4 secretion. Eur. J. Immunol. 22:1757.
36. Fujinami, R. S., P. Y. Paterson, E. D. Day, and V. A. Varitec. 1978. Myelin basic protein serum factor: an endogenous neuroantigen influencing development of experimental allergic encephalomyelitis in Lewis rats. J. Exp. Med. 148:1716.
37. Berger, T., S. Weerth, K. Kojima, C. Linington, H. Wekerle, and H. Lassmann. 1997. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab. Invest. 76:355.
38. Lehmann, P. V., E. E. Sercarz, T. Forsthuber, C. M. Dayan, and G. Gammon. 1993. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol. Today 14:203.
39. Gold, D. P., K. Schroder, H. C. Powell, and C. J. Kelly. 1997. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis. Eur. J. Immunol. 27:2863.
40. Moore, W. M., R. K. Webber, G. M. Jerome, F. S. Tjoeng, T. P. Misko, and M. G. Currie, 1994. L-N6-(1-Iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. J. Med. Chem. 37:3886.
41. Shesely, E. G., N. Meada, H. S. Kim, J. H. Krege, V. E. Laubach, P. A. Sherman, W. C. Sessa, and O. Smithies. 1996. Elevated blood pressure in mice lacking endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 93:13176.
42. Holda J. H., and R H. Swanborg 1982. Autoimmune effector cells. II. Transfer of experimental allergic encephalomyelitis with a subset of T-lymphocytes. Eur. J. Immunol. 12:453.
43. Fenyk-Melody, J. E., A. E. Garrison, S. R. Brunnert, J. R. Weidner, F. Shen, B. A. Shelton, and J. S. Mudgett. 1998. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol. 160:2940.
44. Sahrbacher, U. C., F. Lechner, H. Eugster, K. Frei, H. Lassmann, and A. Fontana. 1998. Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur. J. Immunol. 28: 1332.
45. Sicher, S. C., M. A. Vazquez, and C. Y. Lu. 1994. Inhibition of macrophage Ia expression by nitric oxide. J. Immunol. 153:1293.
46. Albina, J. E., and W. L. Henry. 1991 Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway. J. Surg. Res. 50:403.
47. Mills, C. D. 1991. Molecular basis of "suppressor" macrophages: arginine metabolism via the nitric oxide synthase pathway. J. Immunol. 146:2719.
48. Duhe, R. J., G. A. Evans, R. A. Erwin, R. A. Kirken, G. W. Cox, and W. L. Farrer, 1998. Nitric oxide and thiol redox regulation of Janus kinase activity. Proc. Natl. Acad. Sci. USA 95:126.
49. Taylor-Robinson, AW., F. W. Liew, A. Severn, D. Xu, S. J. McSorley, P. Garside, P., J. Padron, J., and R. Stephen Phillips. 1994. Regulation of the immune response by nitric oxide differentially produced by T helper type-1 and T helper type 2 cells. Eur. J. Immunol. 24:980.
50. Kubes, P., M. Suzuki, and D. N. Granger. 1991. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. 88:4651.
51. De Caterina, R., P. Libby, H. B. Ping, V. J. Thannickal, T. B. Rajavsahisth, M. A. Gimbrone, Jr., W. S. Shin, and J. K. Liao. 1995. Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96:60.
52. Karanth, S., K. Lyson., and S. M. McCann. 1993. Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami. Proc. Natl. Acad. Sci. USA 90:3383.
53. Sandi, C., and C. Gauza. 1995. Evidence for a role for nitric oxide in the corticotropin-releasing factor release induced by interleukin-1β. Eur. J. Pharmacol. 274:17.
54. MacPhee, I. A., F. A. Antoni, and D. W. Mason. 1989. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J. Exp. Med. 169:431.
55. van der Veen, R. C., and Roberts, L. J. 1999. Contrasting roles for nitric oxide and peroxynitrite in the peroxidation of myelin lipids. J. Neuroimmunol. 95:1.